Please assess the completion status of the following clinical trial:

Trial Title: Low Dose Radiotherapy for Advanced Hidradenitis Suppurativa

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of Hidradenitis Suppurativa made at the Montefiore Hidradenitis Suppurativa Treatment Center, with Hurley Stage 2-3 (defined as recurrent abscesses or boils with diffuse or broad involvement, multiple interconnected sinus tracts in the whole area)~* Failed maximal medical therapy for Hidradenitis Suppurativa or ineligible for standard medical therapy or surgery~* Age \> 20 years~* Women of childbearing age: must have a negative pregnancy test within 72 hours prior to the start of study therapy and agree to an adequate method of contraception throughout treatment and for at least 4 weeks after study contraception.~Exclusion Criteria:~* Pregnant women~* Individuals \< 20 years old

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Low Dose Radiotherapy (Type: EXPERIMENTAL): Patients will receive skin-directed radiotherapy, using a total prescription dose of 7.5 gy in five fractions of 1.5 gy over one week

Based on this trial design, predict the completion outcome and termination type (if applicable).